Abstract
The peripheral blood lymphocyte count has been measured in 74 cases of histologically proven carcinoma of the gastrointestinal tract. The count has been correlated with the pathological stage of tumour spread and the patient's delayed hypersensitivity response to 2.4 dinitrochlorobenzene (DNCB). A statistically significant correlation was found between the peripheral blood lymphocyte count and the response to DNCB. There was linear association between the extent of spread of the tumours and the lymphocyte count. Those patients with low peripheral blood lymphocyte counts tended to have more advanced tumours and a poor response to DNCB. The possible causes of this lymphopenia are discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Bone, G., Lauder, I. Cellular Immunity, Peripheral Blood Lymphocyte Count and Pathological Staging of Tumours in the Gastrointestinal Tract. Br J Cancer 30, 215–221 (1974). https://doi.org/10.1038/bjc.1974.184
Issue Date:
DOI: https://doi.org/10.1038/bjc.1974.184
This article is cited by
-
Systemic factors associated with 10-year glaucoma progression in South Korean population: a single center study based on electronic medical records
Scientific Reports (2023)
-
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Journal for ImmunoTherapy of Cancer (2019)
-
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma
Diseases of the Colon & Rectum (1989)